ReviewJ Cancer Res Clin Oncol2016
Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification.
- Journal
- J Cancer Res Clin Oncol
- Published
- 9 May 2016
- Citations
- 28
- Type
- Review
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Purpose Three major chemotherapy strategies have emerged in the treatment of PDAC in the recent past: multiple drug combination, stroma depletion, and use of nanodrug therapy. Anti-diabetic metformin was shown to improve the outcome of a number of cancer types the first seminal report on an observational study published in 2005 and the first hospital-based case-control study on pancreatic cancer in 2009. … Excerpt only: this text is the publisher’s. Read it in full at the source.